Everything you need to cover ImmuneSpan — boilerplate, founder bio, key facts, logos, and press contact. If you need something not listed here, reach out directly.
press@immunespan.comImmuneSpan is an AI-powered immune wellness scoring platform that converts standard bloodwork into a personalized immune age report, calibrated against 128,000+ NHANES participants.
ImmuneSpan is an AI-powered immune wellness platform that converts a standard blood panel into a comprehensive Immune Age report — revealing inflammatory phenotype, population age comparison, and personalized wellness protocols. The platform is trained on 128,000+ NHANES participants using a Cox Proportional Hazards survival model with validated immune biomarker signatures, classifying users into one of 12 proprietary immune phenotype archetypes. Founded by Dr. Geoffrey Stone, Ph.D. in Innate Immunology, ImmuneSpan makes elite biological wellness intelligence accessible to every American at a $29 price point — the cost of a single supplement.
ImmuneSpan is a consumer wellness technology company that translates standard clinical bloodwork into actionable immune wellness intelligence. The platform’s core engine — ImmuneSpan Engine V23, trained on 128,000+ NHANES participant records — applies a Cox Proportional Hazards survival model to produce a Population Inflammatory Age comparison: a scientifically grounded estimate of how a user’s inflammatory biomarker signature compares to population-level aging norms. Users receive one of 12 immune phenotype archetypes (each named and color-coded), a personalized Methuselah Wellness Score, and phenotype-specific supplement, nutrition, and lifestyle protocols grounded in peer-reviewed research. Founded in 2026 by Dr. Geoffrey Stone, Ph.D. — a researcher in innate immunology and clinical oncology — ImmuneSpan operates under a formal IS-REG compliance framework that classifies all outputs as general wellness education under FDA General Wellness Policy (January 2019). The company is headquartered in the United States and reports are delivered via a HIPAA-compliant, pre-signed AWS S3 architecture. ImmuneSpan is for educational purposes only and is not a medical device, diagnostic tool, or substitute for clinical advice.
Dr. Stone’s career spans innate immunology and clinical oncology — two fields that rarely intersect in consumer health technology. His research focus on the Myeloid-Adaptive Bridge — the cellular mechanism by which aging bone marrow shifts from adaptive to myeloid immune cell production — forms the scientific foundation of ImmuneSpan’s scoring methodology.
The founding insight: the neutrophil-to-lymphocyte ratio (NLR) has been validated by over 5,000 peer-reviewed studies as a robust predictor of all-cause mortality and chronic disease risk, yet it appears in every standard annual blood panel and is almost never discussed in routine clinical care. ImmuneSpan was built to close that utility gap.
Dr. Stone built the first version of the ImmuneSpan scoring engine from his own lab results. The V23 engine now runs on 128,000+ NHANES records and produces population-calibrated immune wellness scores with 100 bootstrap iterations for uncertainty quantification.
For high-resolution print-ready files, custom color formats, or SVG versions, email press@immunespan.com. Do not alter the letterforms, colors, or proportions of the ImmuneSpan wordmark.
ImmuneSpan assigns each user one of 12 immune phenotype archetypes — derived from K-means clustering on 64 biomarker features trained on 128,000+ NHANES participants. Each archetype represents a distinct pattern of immune aging with its own primary biological driver and phenotype-specific wellness protocol.
| Specification | Detail |
|---|---|
| Engine Version | ImmuneSpan Engine V23.0.0 |
| Training Dataset | NHANES (National Health and Nutrition Examination Survey) — 128,000+ participants, multiple survey cycles, probability-weighted |
| Core Model | Cox Proportional Hazards survival model with NHANES survey weights (WTMEC2YR). Outcome: all-cause mortality with follow-up years. |
| Age Methodology | Population Inflammatory Age Comparison — PCA-based nearest-neighbor match to NHANES age-band centroid in biomarker space. Not a biological age clock. |
| Biomarker Features | 64 engineered features from CBC + metabolic panel: NLR, SII, SIRI, PLR, LMR, ELR, Platelet Mass, Hepatic Index, Anion Gap, TRIIM Proxy, and more. |
| Phenotype Clustering | K-means (k=12) with rule-based overrides (HbA1c, FIB-4, NLR/CRP/WBC thresholds) |
| Uncertainty Quantification | 100 bootstrap iterations per report |
| Regulatory Classification | FDA General Wellness Policy (January 2019) — Non-Device, Class 1 Entertainment/Wellness. IS-REG framework IS-REG-001 through IS-REG-004. |
| Data Architecture | HIPAA-compliant. PHI stored in AWS S3 (SSE-KMS, CMK). Pre-signed URLs, 1-hour expiry. No biomarker data sent to external LLM APIs. |
| Required Input | Standard CBC + basic metabolic panel. Minimum: WBC, neutrophil %, lymphocyte %, age, sex. Enriched reporting with CRP, albumin, RDW, glucose, HbA1c. |
| Founded | 2026 | United States |
We respond to all press and media inquiries within one business day. For interview requests, please include your publication, deadline, and the angle you’re pursuing.
Interview requests, fact-checking, story pitches, data inquiries, embargoed releases.
press@immunespan.comCorporate wellness programs, longevity clinic integrations, physician partnerships, pharma data licensing inquiries.
partnerships@immunespan.comMethodology questions, algorithm documentation requests, research collaboration inquiries. Dr. Stone is available for technical interviews.
science@immunespan.comReport questions, account issues, billing inquiries, technical support for the analysis platform.
support@immunespan.comResponse time: press and science inquiries — 1 business day. Partnership inquiries — 2–3 business days. ImmuneSpan is a general wellness education platform. All reports include required disclaimers that outputs are not medical diagnoses and do not constitute clinical advice.